Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice
- 1 December 1987
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 93 (4) , 489-493
- https://doi.org/10.1007/bf00207240
Abstract
In order to investigate the behavioural effect of selective blockade of M1 muscarinic receptors in the forebrain, and to characterize a new model for the evaluation of muscarinic agonistic activity, the effect of intrastriatally injected pirenzepine was studied in mice. The direct injection of pirenzepine (0.01–1 μg/mouse) into the right striatum of conscious mice resulted in contralateral turning behaviour. When injected intraperitoneally (IP) 15 min before pirenzepine (1 μg), the muscarinic receptor agonists arecoline and pilocarpine (0.3–3 mg/kg), oxotremorine (0.003–0.03 mg/kg) and RS 86 (0.03–1 mg/kg) antagonized pirenzepine-induced turning, as did the choline-esterase inhibitor physostigmine (0.01–0.1 mg/kg) and the nootropic drug aniracetam (10–30 mg/kg). Haloperidol (0.03–0.3 mg/kg IP) weakly, but significantly, decreased the effect of pirenzepine, whereas (±) sulpiride (3–100 mg/kg) failed to affect it. Finally, (+)-amphetamine (0.1–3 mg/kg IP), citalopram (1–30 mg/kg IP) and muscimol (0.03–0.3 mg/kg IP) failed to modify pirenzepine-induced turning when administered prior to intrastriatal pirenzepine. These results suggest an involvement of M1 muscarinic receptors in rotational behaviour, and indicate that pirenzepine-induced turning may represent a new model for studying the central activity of cholinomimetic drugs.This publication has 17 references indexed in Scilit:
- Effects of acute and chronic injections of carbachol in the rat caudate nucleusPublished by Elsevier ,2002
- HETEROGENEITY OF PRESYNAPTIC MUSCARINIC RECEPTORS REGULATING NEUROTRANSMITTER RELEASE IN THE RAT-BRAIN1984
- Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepineLife Sciences, 1984
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodentsPsychopharmacology, 1982
- The pharmacological assessment of a new, potent oxotremorine analogue in mice and ratsEuropean Journal of Pharmacology, 1982
- Neuropharmacological spectrum of muscimolLife Sciences, 1979
- The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic systemNeuropharmacology, 1978
- Nature and mechanisms of cholinergic-monoaminergic interactions in the brainLife Sciences, 1977
- Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting propertiesEuropean Journal of Pharmacology, 1977